Novel coronavirus disease with conjunctivitis and conjunctivitis as first symptom: Two cases report
10.3760/cma.j.issn.115989-20200303-00133
- VernacularTitle: 首发和伴发结膜炎的新型冠状病毒肺炎患者二例报告
- Author:
Xuejie LI
1
;
Ming WANG
2
;
Jing DAI
3
;
Wenjun WANG
3
;
Yanning YANG
3
;
Wei JIN
3
Author Information
1. The First Affiliated College of Wuhan University, Wuhan 430060, China
2. Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China
3. Eye Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Publication Type:Journal Article
- Keywords:
Novel coronavirus disease;
Conjunctivitis;
Novel coronavirus;
Infectious disease;
Transmisson;
Case report
- From:
Chinese Journal of Experimental Ophthalmology
2020;38(0):E012-E012
- CountryChina
- Language:Chinese
-
Abstract:
As the frontline health care workers at the center of the novel coronavirus disease (COVIN-19) outbreak, we have found many asymptomatic COVIN-19 patients or patients with mild symptoms since December 2019. A number of COVIN-19 cases with conjunctivitis or conjunctivitis as the first symptom have been observed in our clinical work. This paper reports the diagnosis and treatment of one COVIN-19 patient with conjunctivitis as the first symptom and one COVIN-19 patient with conjunctivitis. Case one occurred conjunctivitis at the third day after closely contacted with determined COVID-19 patient and visited to eye doctor, and the symptom of conjunctivitis following the topical administration of anti-virual eyedrops for 1 week, followed by COVID-19. Her 2019-nCoV RNA detection of nasopharynx swab was positive but that of conjunctival sac swab was a negative result. Case two had a positive epidemiological history and simultaneous onset of COVID-19 and conjunctivitis.She presented positive results of 2019-nCoV RNA detection in both nasopharynx and conjunctival sac swabs, and other lab results supported the diagnosis of COVID-19 but she had a normal CT findings of the chest. The ocular symptoms were disappeared after topical administration of anti-virual eyedrops for 1 week.
